What Does an HbA1c of 5.7 Mean?

What this actually measures

HbA1c measures the proportion of haemoglobin — the oxygen-carrying protein inside red blood cells — that has glucose chemically attached to it. Because a red blood cell circulates for roughly three months before the body replaces it, the percentage reflects an average of blood glucose exposure over that stretch, rather than the level in the blood at the exact moment the sample was drawn.

Five point seven is not a rounded-up way of saying “getting close to something.” It is the number printed in the American Diabetes Association’s own diagnostic table as the first value inside the prediabetes band — the line itself, not an approach to it. That distinction matters more than it sounds like it should, because it changes what the result is actually telling you.

Why this particular number, and not 5.6 or 5.8

Cut points on a continuous measurement are always a judgement call about where risk starts climbing meaningfully, and 5.7% is the ADA’s judgement call for HbA1c. Below it, normal. From it up to 6.4%, prediabetes. At 6.5% and above, confirmed on a second test, diabetes.

A result of 5.7% is not, in other words, a fuzzy in-between reading that happens to sit near a boundary. It sits on the boundary — the lowest number that gets the “prediabetes” label rather than the highest number that gets “normal.” A 5.6% and a 5.7% describe two people who are metabolically almost indistinguishable. Only one of them gets a different word printed on the lab report.

What the test is actually measuring

HbA1c measures the share of haemoglobin — the oxygen-carrying protein inside red blood cells — that has glucose chemically attached to it. Glucose sticks to haemoglobin gradually over the roughly three-month life of a red blood cell, so the percentage is closer to a long exposure than a snapshot: it can’t tell you what your blood sugar was yesterday, but a single bad night’s sleep or a late dinner won’t move it either.

That’s also its main limitation. Two people can average the same glucose over three months with very different day-to-day patterns — one steady, one swinging widely — and land on an identical HbA1c. The number reports the average; it doesn’t distinguish a steady average from one built out of highs and lows that cancelled out.

The same result, read against a different rulebook

Here’s the part that rarely makes it into a quick explainer. The ADA’s prediabetes band starts at 5.7%. The threshold used in NHS/NICE guidance in the UK — published, among other places, by North Bristol NHS Trust’s pathology service — starts higher, at 42 mmol/mol, which converts to roughly 6.0%.

Run the arithmetic the other way and 5.7% converts to about 39 mmol/mol. That’s below the UK’s 42 mmol/mol starting point for “increased diabetes risk.” The identical blood sample, run through the identical assay chemistry, gets a different verdict depending on which country’s diagnostic table it’s checked against: prediabetes under American criteria, still within the normal range under the UK’s.

Neither system is wrong. Both are real published thresholds from real clinical guidance bodies, set by people looking at the same kind of outcome data and drawing the line in a slightly different place. What that tells you is something worth sitting with: 5.7% is not a fact about your biology in the way “6.5% or above, confirmed twice” is close to being one. It is a fact about which chart your lab happens to use. The one number every major guideline agrees on is 6.5% (48 mmol/mol) for diabetes itself — that’s the actual hard line, not the prediabetes edge.

Is 5.7% something to actually worry about

No guideline body — not the ADA, not NHS/NICE, not the WHO — publishes a single number it calls “dangerous.” The categories are normal, prediabetes (or “increased risk” in UK terms) and diabetes, and 5.7% is the entry point to the middle one under US criteria specifically.

What would change the picture isn’t the 5.7% itself sitting there unchanged — it’s what a repeat test shows. A result that climbs past 6.4% on a follow-up moves into territory that, confirmed a second time, gets an actual diabetes diagnosis. A result that comes back below 5.7% moves back into normal. A 5.7% sitting still, checked again a year later and still reading 5.7%, is informative in a different, quieter way: it says the number isn’t moving in either direction, which is closer to reassuring than alarming.

That’s also why the ADA’s own diagnostic process calls for repeating a test on a different day, or running a second type of test, before diabetes gets diagnosed at 6.5% or above — with an exception when someone already has clear high-blood-sugar symptoms alongside one very high result. The prediabetes band has no equivalent formal confirmation requirement written into the guideline. That doesn’t mean a recheck is pointless at 5.7%; it means the request for one is coming from good clinical sense rather than from a rule the number itself triggers.

Where a single reading can mislead

The test’s core assumption is that red blood cells are turning over at a normal rate. When that assumption doesn’t hold, the number can shift independent of actual average glucose:

• Recent significant blood loss, or conditions that shorten red blood cell lifespan, give glucose less time to attach, which can read the number lower than true average glucose.
• Recent illness or an inflammatory flare around the time of the blood draw can move a result in either direction on a retest, independent of anything about long-run glucose control.
• Pregnancy changes blood volume and red blood cell turnover in ways that shift the reading, which is why pregnancy has its own separate glucose testing protocols rather than relying on HbA1c alone.

None of this makes HbA1c an unreliable test generally — it’s one of the better-validated tools in routine bloodwork, which is exactly why it’s used for diagnosis at all. It does mean a result that doesn’t match how someone feels, or sits right at a boundary like 5.7%, is a reasonable thing to mention to a clinician rather than read off a chart in isolation.

Where age fits in, and where it doesn’t

Neither the ADA’s thresholds nor the NHS/NICE bands are published with an age adjustment for diagnosis. A 5.7% means the same thing on the diagnostic chart at 30 as it does at 70 — there is no “normal HbA1c for your age” table behind the official criteria, however often that phrase gets searched.

Age does enter the picture, just later in the process. Once diabetes itself is diagnosed, the ADA states that the ongoing treatment target — not the diagnostic threshold, the treatment target — gets individualised by age, life expectancy and other health conditions a person has. That’s a clinician’s decision about managing an existing diagnosis, weighing the risks of tighter control against its benefits for that specific person. It has nothing to do with where the 5.7% line sits on a first reading, and it isn’t something a guide like this one can set for you.

What a sensible next step actually looks like

A 5.7% is a prompt, not a verdict, and treating it as either nothing or an emergency both miss what the number is for. The reasonable version of “taking it seriously” is small and specific: book a follow-up test rather than letting the result sit in a portal for a year, mention it alongside any family history of type 2 diabetes or other risk factors your clinician would want to weigh, and ask which threshold — ADA-style or the narrower UK band — your own lab report is actually using, since that changes which word appears on the page without changing anything about you.